Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Corporate pot is built on mass production and brand names, which Tilray has after merging with Aphria. But legislators seem more interested in accepting decriminalization than pushing corporate weed.

Tilray Stock Almost Certainly Has Another Serious Watering-Down Ahead

Tilray, Inc. (TLRY) CEO Irwin Simon Presents at Oppenheimer 21st Annual Consumer Growth and E-Commerce Conference (Transcript)

Are These Top Marijuana Stocks On Your June Watchlist? The post Top Marijuana Stocks To Watch, Are You Focused on These Companies appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Watch, Are You Focused on These Companies

AMC Entertainment

BARK

BlackBerry

Bed Bath & Beyond

Blink Charging

CoreCivic

Express

GEO Group

GameStop

Nokia

Tanger Factory Outlet Centers

SNDL Inc.

The Reddit retail investing rally can certainly be confusing for investors. But there are a few ways to tell the real winners from the duds.

Short-Squeeze Stocks: How to Tell the Deals From the Duds

Cannabis company Tilray, which recently merged with rival Aphria, has seen its stock surge as of late thanks to — you guessed it — love from the Reddit crowd.

This cannabis stock is a new Reddit favorite

Cronos Group

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

These marijuana stocks are absolute bargains. And they're poised to take off as cannabis becomes legal across the U.S. The post 7 Marijuana Stocks to Buy Now That Look Like Bargains appeared first on InvestorPlace.

7 Marijuana Stocks to Buy Now That Look Like Bargains

3 Ways Trulieve Trounces Sundial Growers and Tilray

Even if TLRY stock misses out on the meme stock wave, additional catalysts could propel it even higher in the coming months. The post It's Pricey, But Tilray Stock Has Room to Run appeared first on InvestorPlace.

It's Pricey, But Tilray Stock Has Room to Run

Investors should not expect to see the cannabis stock grow significantly until there's real headway on federal marijuana legalization.

Tilray Has Little Upside Left in 2021 After 33% Surge, Analyst Says

Markets are watching Tilray's merger with Aphria and waiting for signs that the combined firm will do more than just cut costs. The post Tilray Stock Looks as If It Finally Is on a Sustainable Uptrend appeared first on InvestorPlace.

Tilray Stock Looks as If It Finally Is on a Sustainable Uptrend

This marijuana company was once worth more than Snapchat despite generating negligible revenue. It now seeks to make a comeback.

Is Tilray Headed Back to All-Time Highs?

Cleveland-Cliffs

Clean Energy Fuels

Clover Health Investments

Ocugen, Inc.

United Wholesale Mortgage

Workhorse Group

Meme stocks continue to be a hot topic among Reddit traders and that means there's plenty of discussion taking place over on WallStreetBets. The post Meme Stocks: The Top 10 Reddit Stocks Seeing the Most Chatter Thursday appeared first on InvestorPlace.

Meme Stocks: The Top 10 Reddit Stocks Seeing the Most Chatter Thursday

The shares of Tilray Inc (NASDAQ: TLRY) have received a price target decrease from $30.25 to $22. These are the details.

TLRY Stock Price: $22 Target By Cantor Fitzgerald

Aurora Cannabis

Canopy Growth

GrowGeneration Corp

The so-called “Meme Stock” revolution is upon us. Retail investors and social media trading “gangs” are ganging up on institutional hedge fund shorts and bears with massive implications for the publicly traded stock market.

Is Cannabis the Next Meme Stock Trader Target? (SGMD, TLRY, CGC, SNDL, GRWG, ACB)

Genius Brands

Invesco Mortgage Capital

Root

The WallStreetBets-fueled trading frenzy is spreading to a wider array of companies.

Why GEO Group, Tilray, Genius Brands, and Other Reddit Stocks Surged Today

Together, Tilray and Aphria create a global recreational and medical cannabis powerhouse that have a great chance at coming out on top. The post Relaxed Cannabis Regulations Buoy the Bull Case for Tilray Stock appeared first on InvestorPlace.

Relaxed Cannabis Regulations Buoy the Bull Case for Tilray Stock

Aphria

Tilray looks to keep growing now that it closed its Aphria merger. TLRY stock is based on a lot of hope that the Canadian cannabis market will grow.

Tilray Looks to Keep Growing Now That Its Merger With Aphria Has Closed

It looks like cannabis stocks have entered the  "meme" stock  fray, as shares of Tilray Inc (NASDAQ:TLRY) were last seen up 10.6% at $22.36.

Pot Stock's Options Pits Ignite as Reddit Traders Move In

Cantor Fitgerald upgraded Tilray to overweight. Unfortunately, it also lowered price target for TLRY stock to $22.

Analysts' Latest Move Suggests Tilray's a Buy Under $20

Tilray Inc (NASDAQ:TLRY) is trading higher Wednesday morning amid increased retail interest following the launch of a new medical cannabis brand.  What Happened: Tilray on Tuesday announced Symbios, a new medical cannabis brand it launched in order to provide a broader spectrum of formats and unique cannabinoid ratios at a better price point.

Why Is Tilray Trading Higher Today?

Tilray, Inc. (NASDAQ:TLRY) announced Tuesday the launch of a new medical brand, Symbios, as well as a new line of topical treatments under its Aphria brand. Symbios will offer a range of products including dried flower, oils and pre-rolls while Aphria's new product line is aimed specifically at patients suffering from inflammatory joint disease.

Is Tilray The Next Short Squeeze Candidate?

In the last few months, there was no news bigger than the TLRY-APHA merger. But even after the tie-up, TLRY stock is not a winner.

Tilray Stock Will Keep Disappointing With Poor Numbers and No Catalysts

Here's how they compare in several key areas.

Better Meme Stock: AMC Entertainment or Tilray?

Tilray, Inc. (TLRY) CEO Irwin Simon Presents at Stifel 2021 Virtual Cross Sector Insight Conference (Transcript)

The company now has three medical pot lines.

Tilray Launching New Medical Marijuana Brand

News for Tilray Brands Stock (TLRY)